← All trials
NCT00852423
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jun 1, 2010
- Primary completion
- Oct 1, 2013
- Completion date
- Apr 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 3428
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- Institute of Tropical Medicine, BelgiumLead sponsor
- Centre MurazOverall official - principal investigator
- Institute Tropical Medicine Belgium and MRC Unit in The GambiaStudy chair
- National Institute for Medical Research, TanzaniaCollaborator
- Kwame Nkrumah University of Science and TechnologyCollaborator
- Centre MurazCollaborator
- Tropical Diseases Research Centre, ZambiaCollaborator
- University of LiverpoolCollaborator
- Institute of Tropical Medicine, AmsterdamCollaborator
- University of MalawiCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.